Amphista Therapeutics

Amphista Theraperutics’ Collaboration and License Agreement With Bristol Myers Squibb

By Giulia Di Palma

In UK Gowling WLG, advised on the matter. Gowling WLG advised Amphista Therapeutics with a team including Samuel Beighton (Life Science & Health Care), Patrick Duxbury...

This content is for members only.
Join Now

Already a member? Log in here

Greater London. Greater London Legal Chronicle. May 7, 2022

Amphista Theraperutics’ Collaboration and License Agreement With Merck Healthcare

By Giulia Di Palma

In UK Gowling WLG, advised on the matter. Gowling WLG advised Amphista Therapeutics with a team including Samuel Beighton (Life Science & Health Care), Patrick Duxbury...

This content is for members only.
Join Now

Already a member? Log in here

Greater London. Greater London Legal Chronicle. March 26, 2021

Amphista Therapeutics’ $53 Million Series B Funding Round

By Giulia Di Palma

In UK Osborne Clarke, advised on the matter. Osborne Clarke advised Amphista Therapeutics with a team including Justin Starling (Picture – Corporate M&A). The round was...

This content is for members only.
Join Now

Already a member? Log in here

ALK-Abelló A/S’ Licensing Agreement with ARS Pharmaceuticals Inc.

11x’s $50 Million Series B Funding Round

SHL’s Debt Refinancing

Christies Care’s Acquisition of Daisy Chain Home Support

Becky Adlington and Steve Parry Business Swim!’s MBO From JD Gyms Group

Lisheen H2 Energy Park Limited’s Agreement With Clean Power Hydrogen Group

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

Connelly Group Holdings’ Acquisition of Scottish Security & Fire Systems

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

McDermott Strengthens Global Private Equity Offering With New Hire in London

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

Amphista Theraperutics’ Collaboration and License Agreement With Bristol Myers Squibb

Amphista Theraperutics’ Collaboration and License Agreement With Merck Healthcare

Amphista Therapeutics’ $53 Million Series B Funding Round